Microbicide Trials Network

MTN-003 SSP Manual

DescriptionDateSize
I. Study-Specific Procedures Manual (SSP) Sections VERSION 2
Overview and Version Control2012-Jan-26197.49 KB
Table of Contents2011-May-02103.54 KB
Section 01: Introduction2011-Feb-1885.17 KB
Section 02: Protocol2011-Feb-181.05 MB
Section 03: Documentation Requirements2011-Jun-10297.36 KB
Section 04: Participant Accrual2011-Feb-18267.72 KB
Section 05: Informed Consent2011-Feb-18317.23 KB
Section 06: Participant Follow-up2011-Dec-20916.67 KB
Section 07: Visit Checklists2011-Feb-18551.82 KB
Section 08: Participant Retention2011-Feb-1850.21 KB
Section 09: Study Product Considerations for Non-Pharmacy Staff2011-May-02192.59 KB
Section 10: Clinical Considerations2011-Jun-10489.23 KB
Section 11: Adverse Event Reporting and Safety Monitoring2011-Feb-18759.88 KB
Section 12: Counseling Considerations2011-Sep-22761.02 KB
Section 13: Laboratory Considerations2011-Sep-22992.49 KB
Section 14: Data Collection2011-Feb-181.54 MB
Section 15: Data Communiques2011-Feb-1810.28 KB
Section 15: Data Communiques #42012-Feb-1633.08 KB
Section 16: ACASI Users Manual2011-Feb-181.35 MB
Section 17: Study Reporting Plan2011-Feb-1841.38 KB
Section 18: Bone Mineral Density Substudy (VOICE-B)2012-Jan-19242.83 KB
Section 19: Household and Community Factors Associated with VOICE Product Adherence Substudy (VOICE-C)2012-Jan-26357.29 KB
II. Study-Specific Procedures Manual (SSP) Sections VERSION 1
Overview and Version Control2011-Jan-1846.9 KB
Table of Contents2010-Apr-1697.38 KB
Section 01: Introduction2009-Aug-0784.26 KB
Section 02: Protocol2010-Apr-161.17 MB
Section 03: Documentation Requirements2009-Aug-07156.49 KB
Section 04: Participant Accrual2010-Nov-24202.9 KB
Section 05: Informed Consent2010-Apr-16282.8 KB
Section 06: Participant Follow-up2010-Nov-24329.72 KB
Section 07: Visit Checklists2010-Apr-161.2 MB
Section 08: Participant Retention2009-Aug-07109.35 KB
Section 09: Study Product Considerations for Non-Pharmacy Staff2010-Apr-16270.62 KB
Section 10: Clinical Considerations2010-Nov-24503.73 KB
Section 11: Adverse Event Reporting and Safety Monitoring2010-Apr-16213 KB
Section 12: Counseling Considerations2009-Aug-07434.32 KB
Section 13: Laboratory Considerations2010-Nov-24306.39 KB
Section 14: Data Collection2009-Aug-071.58 MB
Section 15: Data Communiques2009-Aug-0714.24 KB
Section 15: Data Communiques #12009-Sep-0951.22 KB
Section 15: Data Communiques #22009-Dec-1636.78 KB
Section 15: Data Communiques #32010-Apr-16331.94 KB
Section 16: ACASI Users Manual2010-Nov-241.14 MB
Section 17: Study Reporting Plan2009-Aug-0744.69 KB
Section 18: Bone Mineral Density Substudy (VOICE-B)2012-Jan-19242.83 KB
Section 19: Household and Community Factors Associated with VOICE Product Adherence Substudy (VOICE-C)2012-Jan-26357.29 KB